Matrix-metalloproteases (MMPs) and their tissue-inhibitors (TIMPs), modulated by different single nucleotide polymorphisms (SNPs), are critical in sepsis development. Ninety ICU severely septic and 91 ICU uninfected patients were prospectively studied. MMP-1 (21607 1G/2G), MMP-3 (21612 5A/6A), MMP-8 (2799 C/T), MMP-9 (21562 C/T), and MMP-13 (277A/G) SNPs were genotyped. Plasma MMPs (-1, -2, -3, -8, -9, -10, -13) and TIMPs (-1,-2,-4) were measured. AA homozygotes and A allele carriers of MMP-13 (277 A/G) and 1G2G carriers of the MMP-1 (21607 1G/2G) SNPs frequencies were different between septic and uninfected patients (p , 0.05), as well as plasma MMP-3, -8, -9 -10 and TIMP-2 levels (p , 0.04). No differences in MMPs levels among MMP-13 or MMP-1 SNPs genotypes carriers were observed. The area under the ROC curve for MMP-8 in the diagnosis of sepsis was 0.87 (95% CI 0.82-0.92), and that of CRP was 0.98 (0.94-0.998), whereas the area of MMP-9 in the detection of non-septic state was 0.73 (0.65-0.80), p , 0.0001 for all curves. Sepsis associated with increased MMP-8 and decreased MMP-9 levels in multivariate analysis (p , 0.0002). We report for the first time an association between MMP-13 and MMP-1 SNPs and sepsis. An independent association of MMP-8 and MMP-9 levels with sepsis was also observed. S eptic shock is the most common cause of death in the Intensive Care Units (ICU). Despite modern intensive care and antibiotic treatments the mortality of sepsis still remains high, ranging from 20% to 30% in septic shock 1, 2 . The role of the immune system in the pathophysiology of septic shock (cytokines, neutrophils, monocytes, macrophages) has been well documented but little is known regarding the role of extracellular matrix metalloproteases (MMPs) 3,4 . MMPS are a family of zinc-dependent endoproteases that share amino-acid sequences, structural domains and substrates and can degrade the extracellular matrix (ECM) proteins. Their activity depends on activation of MMPs zymogens and is influenced by tissue inhibitors (TIMPs). MMPs are involved in the response to tissue injury and inflammation and are stimulated by cytokines. MMPs activity is increased in inflammatory diseases, acute respiratory distress syndrome (ARDS) and in response to endotoxin injection. Some MMPs, such as MMP-8 and -9, are stored in neutrophils granules and are liberated by endotoxin. MMPs release membrane-bound cytokines such as TNF-a. MMPs cleavage of ECM collagen present in membranes basement might help neutrophils crossing blood and lymph circulation into sites of infection 5, 6 . There is a large and ever increasing family of mammalian MMPs that are broadly divided in different subfamilies according to their substrate specificity. Gelatinases (MMP-2 and -9) have been related to sepsis so far although less attention has been paid to collagenases (MMP-1, -13) and stromelysins . This is important considering the central role played by MMP-3 and especially MMP-13 in the MMPs activation cascade 7 . Previous studies have found increased serum levels of most of the MMPs and TIMPs in sepsis although results are far from clear [8] [9] [10] [11] [12] [13] [14] [15] 
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eptic shock is the most common cause of death in the Intensive Care Units (ICU). Despite modern intensive care and antibiotic treatments the mortality of sepsis still remains high, ranging from 20% to 30% in septic shock 1, 2 . The role of the immune system in the pathophysiology of septic shock (cytokines, neutrophils, monocytes, macrophages) has been well documented but little is known regarding the role of extracellular matrix metalloproteases (MMPs) 3, 4 . MMPS are a family of zinc-dependent endoproteases that share amino-acid sequences, structural domains and substrates and can degrade the extracellular matrix (ECM) proteins. Their activity depends on activation of MMPs zymogens and is influenced by tissue inhibitors (TIMPs). MMPs are involved in the response to tissue injury and inflammation and are stimulated by cytokines. MMPs activity is increased in inflammatory diseases, acute respiratory distress syndrome (ARDS) and in response to endotoxin injection. Some MMPs, such as MMP-8 and -9, are stored in neutrophils granules and are liberated by endotoxin. MMPs release membrane-bound cytokines such as TNF-a. MMPs cleavage of ECM collagen present in membranes basement might help neutrophils crossing blood and lymph circulation into sites of infection 5, 6 . There is a large and ever increasing family of mammalian MMPs that are broadly divided in different subfamilies according to their substrate specificity. Gelatinases (MMP-2 and -9) have been related to sepsis so far although less attention has been paid to collagenases (MMP-1, -13) and stromelysins (MMP-3, -10). This is important considering the central role played by MMP-3 and especially MMP-13 in the MMPs activation cascade 7 . Previous studies have found increased serum levels of most of the MMPs and TIMPs in sepsis although results are far from clear [8] [9] [10] [11] [12] [13] [14] [15] . Only three studies centered on the time course of MMPs and TIMPs so far, two of them only tangentially [12] [13] [14] . Different polymorphisms (SNPs) of MMPs and TIMPs have been described. Some of them such as the MMP-3 (-1612 5A/6A), MMP-9(-1562 C/T) and MMP-13 (-77 A/G) are located in the MMPs genes promoter region and induce changes in MMPs genes mRNA and protein expression 16 . These functional MMPs SNPs are associated mostly with cardiovascular disease susceptibility, but also with cancer, rheumatic diseases and other conditions, such as endometriosis [16] [17] [18] [19] [20] [21] [22] [23] [24] . To our knowledge, only two papers on MMPs SNPs and infection have been published, one reporting an association of a MMP9 SNP with periodontitis susceptibility 25 and a second, from our group, of a MMP1 SNP with bacterial osteomyelitis 26 . Very recently an association between a TIMP1 SNP and sepsis mortality has been published 27 . The aims of this study were: 1. to investigate the baseline and time course plasma levels of MMPs and TIMPs in ICU septic and uninfected patients; 2. to investigate whether MMPs SNPs might associate with susceptibility to sepsis or influence the sepsis outcome, with/out associated changes in plasma MMPs and TIMPs levels. In order to answer these questions, plasma levels of different MMPs and TIMPs were measured and different SNPs of MMPs were genotyped in septic and uninfected control patients. The time course of MMPs and TIMPs at days 1, 3 and 7 of ICU admission in a subgroup of septic patients and uninfected controls was also analyzed. 28, 29 . In addition, all septic patients had positive blood cultures or a microbiologically-demonstrated source of bacterial infection at ICU admission. All infections were community-acquired. Patients with cancer, HIV infection, transplantation or other causes of immunodepression were excluded. Ninety one uninfected patients admitted to the ICU for other non-infective diseases, mostly severe trauma and brain strokes, were used as controls. If a control patient developed an ICU infection during the follow-up was excluded from the control group. APACHE II scores and number of organ failures were calculated in septic patients and uninfected controls. Patients and controls were members of a homogeneous Caucasian population, and were residents of the same region (Asturias, Northern Spain) that has a small foreign immigrant population (less than 5%). Each participant or their legal representatives gave informed consent for the study, which was approved by the Ethics Committee of the HUCA. Organ dysfunction failures were defined according to Marshall 30 . Treatment of organ failures, volume resuscitation, and supportive therapy for sepsis were based on currently applied guidelines 31 . Fluid resuscitation with crystalloids and colloids, early broad spectrum antibiotic treatment (most commonly broad spectrum b-lactamics such as carbapenems or piperacillin-tazobactam with or without aminoglycosides), norepinephrine with or without dobutamine in case of hemodynamic shock, infusion of iv insulin for glucose level control, furosemide with hemofiltration in oliguria or anuria, stress ulcer prophylaxis with omeprazole, and thrombosis prophylaxis with enoxaparine or fraxiparine were administered. Morphine and propofol were used for analgesia and sedation during mechanical ventilation at appropriate doses. None of the patients received drotrecogin alfa.
Methods

Patients
Methods. All the experiments described here were performed in accordance with the regulations issued by the Ethics Committee of the HUCA.
Plasma MMPs and TIMPs. Ten ml of blood were drawn by venipuncture in EDTAcontaining tubes within the first 24 hours of ICU admission in all the individuals, and in a subgroup of 14 sepsis patients and 18 controls samples were also obtained at days 1, 3 and 7 of ICU stay. Tubes were centrifuged for 5 minutes at 1,800 g and serum was removed and frozen at 280uC until use. Plasma levels of MMPs-1, -2, -3, -8, -9, -10 and -13 and TIMP -1, -2, and -4 were measured using the Quantibody TM Human MMP Array 1 from Raybiotech (Raybiotech, Parkway Lane, Norcross, GA, USA) according to the manufacturer's instructions 26 .
MMPs SNPs genotyping. DNA was obtained from peripheral blood cells and stored at 220uC before use. The following SNPs of MMPs were genotyped by PCR: MMP-1 (21607 1G/2G, rs 11292517), MMP-3 (21612 5A/6A, rs35068180), MMP-8 (2799 C/T, rs 11225395), MMP-9 (21562 C/T, rs 34016235), and MMP-13 (277 A/G, rs 2252070). Oligonucleotide primer sequences, PCR conditions and restriction enzymes used for genotyping and sequencing the different matrix metalloproteases (MMPs) polymorphisms studied are described elsewhere 16, 22, 24, 26 .
Other laboratory analysis. A complete hemogram, coagulation, general biochemistry, and C-reactive protein (CRP) levels were obtained from patients and controls at day 1 of ICU admission. 
Results
Patients clinical and laboratory characteristics and outcome. Septic and uninfected ICU patients were matched in age and sex. There were no differences regarding the APACHE II score. A total of 21 individuals died (11.6%). Although more uninfected controls died there were not statistically significant differences compared to the septic patients. As expected, the number of organ failures has significantly higher in septic patients. Table 1 shows the demographic and clinical characteristics of both groups, and Table 2 the laboratory results. We observed significantly higher levels of neutrophils, CRP and plasma MMP-3, -8, -10, and TIMP-2 and lower concentrations of MMP-9 in septic patients compared to uninfected controls at day 1 of ICU admission. MMP-8 correlated positively (r 5 0.39, p , 0.0001) and MMP-9 negatively (r 5 20.29, p 5 0.003) with CRP levels. The remaining MMPs and TIMPs did not show any significant correlation with CRP (p 5 0.07 to p 5 0.9). Plasma levels of MMP-2 and MMP-13 were significantly increased in septic survivors compared to non-survivors (Table 3 ).
MMPs SNPs. Table 4 shows the genotypic and allelic frequencies in septic and control patients. Of all the MMPs SNPs studied we only found that the AA genotype of the MMP-13 (277 A/G) SNP was significantly more frequent and the 1G2G genotype of the MMP-1(21607 1G/2G) less frequent in septic patients compared to uninfected ICU controls. The A allele of the MMP-13 SNP was also significantly more frequent in septic patients compared to uninfected controls. No differences in plasma MMPs levels in carriers of the different genotypes of the MMP-13 (277 A/G) and of the MMP-1(21607 1G/2G) SNPs were observed (data not shown). Septic carriers of the MMP-3(21612 5A/6A) genotype had significantly higher plasma levels of MMP-3 compared to those with the 5A5A genotype and to uninfected controls ( Figure 1) .
Due to the relatively small number of non-survivors in the sepsis group (7 patients) it is difficult to draw definitive conclusions regarding the MMPs SNPs studied and mortality. No associations with the APACHE II score or the number of organ failures were observed for any of the MMPs SNPs studied.
Logistic regression analysis. Variables with a p value , 0.1 in the univariate comparisons were used for the logistic regression analysis. On the contrary, there were no statistically significant differences over time for any MMP or TIMP in the control group (Fig. 2, A-F) .
The slopes of the MMPs and TIMPs curves over time were significantly different between septic and uninfected control patients only 
Discussion
We report here for the first time an association between the MMP-13 (277 A/G) and the MMP-1 (21607 1G/2G) SNPs and sepsis. The MMP-13 SNP association with sepsis we report might not be surprising considering the central role of MMP-13 in the MMPs activation cascade and the involvement of MMPs in inflammation and response to endotoxin 7 . However the mechanism by which carriers of the AA genotype and the A allele of this MMP-13 SNP develop more easily sepsis is not well understood. We could not find an association between changes of plasma MMP-13 levels and the different genotypes of the MMP-13 SNP. However, the expression of Borghese et al have confirmed the linkage disequilibrium between the MMP-13 and MMP-1 SNPs in a large multi-ethnic genetic study. In addition they reported allelic frequencies of the MMP-1, MMP-3 and MMP-13 SNPs in healthy French Caucasians women similar to those observed in the ICU uninfected controls in our study 24 . The association of MMPs SNPs and infection was been rarely explored so far. We have previously reported an association of the MMP-1 (-1607 1G/2G, rs 11292517) SNP with bacterial osteomyelitis due to an increased bone expression and plasma levels of MMP-1 in carriers of 2G2G genotype of the MMP-1 SNP 26 . Pan et al also reported an association of chronic periodontitis with the carriage . The 6A6A genotype of the MMP-3(-1612 5A/6A) SNP has been previously associated with a lower gene expression of the MMP-3 gen and lower MMP-3 plasma levels compared to those carriers of the 5A5A genotype [16] [17] [18] [19] . However other studies have reported that carriers of the 6A6A genotype of this MMP-3 SNP had higher plasma MMP-3 levels [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . Our results were similar to the latter studies although only in septic patients but not in the uninfected controls, which is intriguing and needs further exploration. The MMP-3 SNP has been associated with different forms of cardiovascular disease, including severe coronary disease and myocardial infarction but not with sepsis or infection 16, 33, 34 .
We also observed, as other authors did, increased plasma levels of most of the MMPs, except MMP-9, and TIMP-2 in septic patients but not in the uninfected controls. CRP plasma levels correlated positively with those of MMP-8 and negatively with those of MMP-9. Plasma MMP-9 levels were lower in septic patients compared to those of the controls, a fact to consider because decreased plasma MMP-9 levels were associated with sepsis in the multivariate logistic regression in our study. The implication of gelatinases (MMP-2 and MMP-9), both secreted by the circulating neutrophils, in sepsis pathophysiology is well documented 8, [10] [11] [12] [13] [14] [15] . We bring forward now the potential role of collagenases (MMP-13 and MMP-1) and perhaps stromelysins (MMP-3) in sepsis, an interesting finding because these MMPs are neither expressed in neutrophils nor released from neutrophils granules after endotoxin challenge as MMP-8 and MMP-9 do 5 . The association of MMP-1 with sepsis has been recently reported. Tressel et al observed that MMP-1 appeared just a few hours after sepsis in human septic patients and in a murine model. In addition a MMP-1 inhibitor blocked experimentally-induced sepsis in the same animals 35 . MMP-1 is expressed by unstressed endothelial cells and secreted by these cells in sepsis. This fact leads to protease-activated receptor 1 (PAR1) activation, vascular permeability, clotting abnormalities and production of cytokines and prostaglandins 36 .
Regarding the MMPs and TIMPs time course it is important to keep in mind that MMP-1, and MMP-9 plasma levels in septic patients peaked at day 7 of ICU stay from admission levels in our study. On the contrary MMP-3, MMP-8, MMP-10 and TIMP-4 had their nadir serum levels at day 7 of ICU stay. This might be one of the reasons of the disparity in plasma MMPs levels data in our study compared to previous reports in which blood was mostly drawn only within the day 1 or at random during the ICU stay. We could not find differences between TIMP-1 plasma levels of ICU septic and uninfected patients or among non-surviving and surviving septic patients. TIMP-1 has been proposed as a useful laboratory marker to predict the clinical outcome of septic patients 10, 11 . Furthermore, carriers of the T allele in the TIMP-1 (372 T/C) SNP (rs4898) showed higher serum TIMP-1 levels and lower survival rate among septic patients in one study 27 . The low death rate among septic patients in our cohort (7.8%) has limited the statistical significance of TIMP-1 and the rest of data analyzed. The low mortality rate in this septic cohort of ICU patients with a mean of 3 organ failures might be due to the very restrictive inclusion criteria we used in our study excluding patients with cancer, HIV infection, transplantation or other causes of immunodepression, patients normally included in previous ICU sepsis series. This restrictive inclusion criteria has also limited greatly the number of septic patients enrolled and expanded the recruitment window of the study to more than 3 years.
We can summarize our findings on MMPs in sepsis pathophysiology as follows. Bacterial endotoxin stimulates the release of cytokines that contribute to the expression and release of MMPs from endothelial cells (MMP-1) or from neutrophils (MMP-8 and MMP-9). In addition MMPs activate cytokines precursors in a self-perpetuating vicious circle. MMP-13 has a leading role in the MMPs-activation process and a MMP-13 SNP influencing MMP-13 expression might contribute to sepsis enhancement as we found 7 . Among the MMPs showing earlier increased plasma levels in sepsis were MMP-3, -8, and -10 as we observed while others like MMP-1 and -9 increased later. High MMP-8 and low MMP-9, which correlated with plasma CRP levels, were associated with sepsis, in addition to high fibrinogen levels and neutrophils counts. Some of the MMPs laterly increased in plasma, such as MMP-1, lead to sepsis-associated clotting abnormalities. Other MMPs through membranes basement ECM collagen cleavage help neutrophils crossing from blood and lymph vessels to the infection locus. Finally some MMPs, including MMP-1, contribute to tissue repair once the infection has subsided 5 .Therefore a MMP-1 SNP that influence MMP-1 expression might play a dual effect in both sepsis enhancement and in inflammation-damaged tissue repair.
Some papers based on the role of MMPs and TIMPs in sepsis have been published in the last 15 years [8] [9] [10] [11] [12] [13] [14] [15] . The main limitations of these studies are: 1. small size; 2. enrollment of healthy controls instead of ICU uninfected patients; and 3. the lack of exclusion criteria for patients with underlying immunodeficiencies 37 . Our cohort, made of 90 septic patients was the only one enrolled from one single hospital. In addition we included uninfected 91 ICU patients as controls instead of healthy individuals, something rarely done and we excluded patients with underlying immunodeficiencies, a fact not previously considered. The main limitations of our study in addition to the relatively small sample size and the low septic patients mortality is our only Caucasian population. More research in multi-ethnic larger populations of septic patients is needed to confirm our findings.
In conclusion, we report for the first time an association between the MMP-13 and the MMP-1 SNPs and sepsis, as well as an independent association of plasma MMP-8 and MMP-9 levels with sepsis. The role of MMPs and their SNPs in sepsis development needs further research.
